|
Dr. Loring’s primary research interests are in drug discovery in human embryonic stem cells, gene expression profiling (microarray) to characterize models of human disease and discovery of novel therapies for Alzheimer’s disease. Dr. Loring generated nine of the approximately 60 human embryonic stem cell derivations that were recognized in 2001 by the NIH as eligible for federal funding. Dr. Loring joined the faculty of Burnham Institute as a principal investigator in 2004. Prior to the Burnham, Dr. Loring held positions in senior research management at several biotech companies including Incyte Genomics and GenPharm International as well as a past faculty position in Embryology at the University of California at Davis. Dr. Loring holds a bachelor’s degree in Molecular Biology (magna cum laude) from the University of Washington and a Ph.D. in Developmental Neurobiology from the University of Oregon. Dr. Loring also serves on the scientific review boards of the NIH Brain Disorders/Clinical Neurosciences Study Section and the scientific advisory council of the Alzheimer’s Association. | 